Trial intelligence / Profile preview

Subanesthetic-dose esketamine for postoperative pain in elderly orthopedic patients

ChiCTR2000040174Phase 4Not yet recruiting

Sponsor
The Second Xiangya Hospital
Start
Nov 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of esketamine in postoperative pain (3 arms), sponsored by The Second Xiangya Hospital. Primary endpoints: VAS score, CAM score and 1 more. Planned start Nov 2020; status: not yet recruiting.

02

Drugs

esketamine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on ChiCTR2000040174.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000040174.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call